To ensure certain safety measures are utilized in the interest of public health security with respect to labeling and transporting human tissue specimen or collection of specimens into interstate commerce.
USA115th CongressHR-2022| House
| Updated: 4/7/2017
Paul A. Gosar
Republican Representative
Arizona
Cosponsors (4)
Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Label and Transport Tissues Safely Act of 2017 or the LATTS Act of 2017 This bill prohibits the sale of human tissue for research or education unless the seller has a non-transplant tissue bank license, each package of tissue is labeled with specified information, and each package is wrapped in the prescribed manner. The Department of Health and Human Services (HHS) shall establish a process for the approval, suspension, and revocation of non-transplant tissue bank licenses. False labeling of packages of human tissue is prohibited. HHS or any accrediting body authorized by HHS is allowed to enter and inspect any facility that is subject to a non-transplant tissue bank license. HHS shall recall any human tissue specimen that is an imminent or substantial hazard to public health. The bill makes it unlawful to knowingly sell or otherwise transfer any human tissue specimen if the transfer affects interstate commerce.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Health
Administrative law and regulatory proceduresBusiness recordsDepartment of Health and Human ServicesFraud offenses and financial crimesHazardous wastes and toxic substancesHealth information and medical recordsInfectious and parasitic diseasesLicensing and registrationsMedical educationMedical researchOrgan and tissue donation and transplantationProduct safety and quality
To ensure certain safety measures are utilized in the interest of public health security with respect to labeling and transporting human tissue specimen or collection of specimens into interstate commerce.
USA115th CongressHR-2022| House
| Updated: 4/7/2017
Label and Transport Tissues Safely Act of 2017 or the LATTS Act of 2017 This bill prohibits the sale of human tissue for research or education unless the seller has a non-transplant tissue bank license, each package of tissue is labeled with specified information, and each package is wrapped in the prescribed manner. The Department of Health and Human Services (HHS) shall establish a process for the approval, suspension, and revocation of non-transplant tissue bank licenses. False labeling of packages of human tissue is prohibited. HHS or any accrediting body authorized by HHS is allowed to enter and inspect any facility that is subject to a non-transplant tissue bank license. HHS shall recall any human tissue specimen that is an imminent or substantial hazard to public health. The bill makes it unlawful to knowingly sell or otherwise transfer any human tissue specimen if the transfer affects interstate commerce.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Paul A. Gosar
Republican Representative
Arizona
Cosponsors (4)
Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Administrative law and regulatory proceduresBusiness recordsDepartment of Health and Human ServicesFraud offenses and financial crimesHazardous wastes and toxic substancesHealth information and medical recordsInfectious and parasitic diseasesLicensing and registrationsMedical educationMedical researchOrgan and tissue donation and transplantationProduct safety and quality